0001209191-13-048099.txt : 20131011 0001209191-13-048099.hdr.sgml : 20131011 20131011093800 ACCESSION NUMBER: 0001209191-13-048099 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130912 FILED AS OF DATE: 20131011 DATE AS OF CHANGE: 20131011 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: REGENERX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0000707511 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521253406 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 BUSINESS PHONE: 3019611992 MAIL ADDRESS: STREET 1: 3 BETHESDA METRO CENTER STREET 2: SUITE 700 CITY: BETHESDA STATE: MD ZIP: 20814 FORMER COMPANY: FORMER CONFORMED NAME: ALPHA 1 BIOMEDICALS INC DATE OF NAME CHANGE: 19950719 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bowles L Thompson CENTRAL INDEX KEY: 0001355785 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15070 FILM NUMBER: 131147061 MAIL ADDRESS: STREET 1: C/O REGENERX BIOPHARMACEUTICALS, INC. STREET 2: 3 BETHESDA METRO CENTER ? SUITE 630 CITY: BETHESDA STATE: MD ZIP: 20814 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2013-09-12 0 0000707511 REGENERX BIOPHARMACEUTICALS INC RGRX 0001355785 Bowles L Thompson C/O REGENERX BIOPHARMACEUTICALS, INC. 15245 SHADY GROVE ROAD, SUITE 470 ROCKVILLE MD 20850 1 0 0 0 Convertible Promissory Note (right to buy) 0.06 2013-09-12 4 A 0 5000.00 5000.00 A 2013-09-12 2018-09-10 Common Stock 83333 5000.00 D Represents the principal amount of the Convertible Promissory Note issued by the issuer to the reporting person on September 12, 2013. Represents the shares of common stock issuable upon conversion of the principal amount of the Convertible Promissory Note. /s/ J.J. Finkelstein, Attorney-in-Fact 2013-10-11